Stimulation of HLA-DR antigen expression in acute and chronic leukemias

Cancer Research, Therapy and Control

Volumn 10, Issue 1-2, 1999, Pages 93-99

  Castro, F A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone marrow transplantation; Cytokines; Graft versus leukemia; Hla typing; HLA DR; Leukemia

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INTERLEUKIN 2; LECTIN; PHYTOHEMAGGLUTININ; RECOMBINANT GAMMA INTERFERON;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034059521     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abbas AK, Lichtman AH & Pober JS ( 1997). The major histocompatibility complex. In: Abbas AK, Lichtman AH, Pober JS, ed. Cellular and Molecular Immunology. 3rd ed. Philadelphia, W.B. Saunders, p. 96-115.
2. Amiot L, Onno M, Lamy T, Dauric C, Prise PY, Fauchet R & Drenou B (1998). Loss of HLA molecules in B lymphomas is associated with an agressive clinical course. Br J Haematol, 100:655-663.
3. Bain B, Vas MR & Lowenstein L (1964). The development of large immature mononuclear cells in mixed lymphocyte cultures. Blood 23: 108-127.
4. Basham TY & Merigan TC (1983). Recombinant interferon-y increases HLA-DR synthesis and expression. J Immunol, 130: 1942-1947.
5. Barret AJ & Malkovska V (1996). Graft-versus-leukemia: understanding and using the alloimmune response to treat haematological malignancies. Br J. Haematol 93: 754-761.
6. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB and Gorski J (1992). The predictive value of HLA-DR oligotyping for MLC responses. Transplantation, 53: 1352-1357.
7. Bosslet K & Schirrmacher V ( 1981 ). Escape of metastasizing clonal tumor cell variants from tumor specific cytolytic T lymphocytes. J Exp Med 154: 557-562.
8. Boyum A (1968). Separation of leukocytes from blood and bone marrow. ScandJ Clin Lab Invest 21 (Suppl 97): 77-89.
9. Büx J, Spengel U & Muller-Eckhart (1993). Quantification of HLA class II on B-cell lines. Eur J Immunogenet 20(3): 189-192.
10. Clorvath B, Sedlak J, Speiser P & Zeillinger R (1992). Cytokine (IFN-a, IFN-y, IL-l-a, TNF-a) induced modulation of HLA cell surface expression in human breast cancer cell lines. Neoplasma, 39: 269-272.
11. (11] Dazzi F. d'Andréa E, Biasi G, De Silvestro G, Gaidano G, Schena M, Tison T, Vianello F, Girolani A & Caligaris-Cappio F (1995). Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol, 75: 26-32.
12. Dermime S, Mavroudis D, Juang Y-Z, Hensel N, Molldrem J & Barrett AJ ( 1997). Immune escape from a graft-versus-leukemia effect may play a role in relapse of myeloid leukemias following allogeneic bone marrow transplantation. Bone Marrow Transplant, 19: 989-999.
13. Erb KJ, Holtschke T, Muth K, Horak l & Schimpl A (1994). T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur J Immunol, 24: 1143-1147.
14. Farrar JJ, Benjamin WR, Hilfiker ML & Howard M ( 1982). The biochemistry, biology and role of IL-2 in induction of citotoxic T cells and antibody-forming B cells responses. Immunol Rev, 63: 129-166.
15. Fauser AA, Kanz L, Brass KJ & Löhr GW (1985). T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia. J Clin Invest, 75: l OSO1082.
16. Flavell RA, Peterlin M, Fontes JD & Chang CH (1994). Class II transactivator (CIITA) is sufficient for inducible expression of major histocompatibility complex class II genes. The J Exp Med, 180:1367-1374.
17. Giacomini P, Aguzzi A, Pestka S, fisher PB & Ferrone S (1984). Modulation by recombinant DNA leukocytes and fibroblasts interferons of expression and shedding of HLA and tumor associated antigens by melanoma cells. J Immunol, 133: 1649-1655.
18. Glimcher LH & Kara CJ (1992). Sequences and factors: a guide to MHC class-II transcription. Anna Rev Immunol, 10: 1349.
19. Go NF. Castle BE, Barret R, Kastelein R, Dang W, Mosmann TR. Moore KW & Howard M (1990). Interleulin-10. a novel B cell stimulatory factor: unresponsiveness of X chromossome-linked immunodeficiency B cells. J Exp Med.VTi'. 1625-1631.
20. Guy K, Docherty LJ & Dewar AE (1986). Deficient expression of MHC class II antigens in some cases of human B cell leukemia. Clin Exp Immunol 63: 290-297.
21. Haferlach T. Winkemann M, Nickenig C, Meeder M, Ramm-Petersen L, Schoch R, Nickelsen M & Weber-Matthiesen K (1996). Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at single cell level by combining May-Griinwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol, 97: 99-106.
22. [22[ Howard M. Malis L. Malek TR, Shevach E, Kell W & Cohen D (1983). Interleukin-2 induces antigen reactive T cells lines to secrete BCGF-l.JExpMed, 158: 2024-2039.
23. Kaufman JF, Aufffray C, Korman AJ, Shakelford, DA & Strominger JL. (1984). The class II molecules of human and murine major histocompatibility complex. Cell, 36: 1-13.
24. Kraiba R. Loiseau P. Faule A. Poirer O. Piatier-Tonneau D, Degos L, Abita JP & Charron D. (1989). HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein and mRNA studies. Leukemia. 3: 386-393.
25. Lecchi M, Lovisone E, Genetta C, Peruccio D, Resegotti L & Richiardi P ( I989|. y-interferon induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Leukemia Res, 13: 221-226.
26. Mach B, Steimle V. Martinez-Soria E & Reith W (1996). Regulation of MHC Class II genes: Lessons from a disease. Anna Rev of Immunol, 14: 301-331.
27. Maffei A & Guardiola J (1993). Control of MHC class II genes expression in autoimmune, infectious and neoplastic diseases. Crit Rev Immunol, 13: 247-268.
28. Miller P, Hermann B, MoldenhauerG & Moller P (1987). Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int J Cancer, 40 : 32-39.
29. Miyawaki T, Seki H, Taga k, Sato H & Taniguchi N (1985). Dissociated production of interleukin-2 immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol 59(2): 505-511.
30. Momburg F, Hermann B, Moldenhauer G & Moller P (1987). B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, DQ and DP antigens and associated invariant chain. Int J Cancer, 40: 598-603.
31. Pesando JM & Graf L (1986). Differential expression of HLA-DR, DQ and DP antigens on malignant B cells. J Immunol, 136:4311-4318.
32. Pesando JM, Graf L & Hoffman P (1986). HLA-DP can be expressed with or without DR molecules on malignant B cell \me.Jlmmunol, 137: 1932-1936.
33. Piatier-Tonneau D, Turmel P, Aufffray C & Charron D ( 1986). Construction of chain and locus specific HLA class II DNA probes. Study of HLA class II transcripts in leukemias. J Immunol, 137: 2050-2056.
34. Radvany RM & Vaisrub N (1984). HLA-DR typing as a predictor of MLC compatibility. Transplantation, 38(4): 347351.
35. Raffoux C, Lethielleux P & Colombani J (1989). Typage HLA classe II des leucemises myeloides chroniques par la reaction de fixation du complement sur lymphocytes stimules par la phytohemagglutinine en presence d'interleukine-2 et d'interferon gamma. Rev Fr Transfus Hemabiol, 32(3): 193202.
36. Robbins PA, Brodsky FM, Warner NL & Maino VC (1984). Induction of class II antigens on monocytes cultured with gamma-interferon. Dis Markers, 2: 267-270.
37. [37[ Rosa F, Hatat D, Abadie A, Wallach D, Revel M & Fellous M (1983). Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J, 2: 1585-1589.
38. [38[ Schultz KR, Klarnet JP, Gieni RS, HayGlass KT & Greenberg PD (1990). The role of B cells for in vivo T cell responses to Friend virus-induced leukemia. Science 249: 921-923.
39. Terasaki PI, MacLelland J, Parks MS & McCurly B (1974). Microdroplet lymphocyte cytotoxicity test. In "Ray JG, Hare DB, Pedersen PD & Kayhoe DE", eds. Manual of Tissue Typing Techniques, NIH, Bethesda, p. 66.